Lymphocyte infiltrates as a prognostic variable in female breast cancer

S Aaltomaa, P Lipponen, M Eskelinen… - European journal of …, 1992 - Elsevier
The predictive value of lymphocyte infiltrates (LI) was studied in 489 patients with breast
cancer followed-up for over 10 years. LI were positively correlated to axillary lymph-node …

Prognostic factors in early breast carcinoma

EG Mansour, PM Ravdin, L Dressier - Cancer, 1994 - Wiley Online Library
Several investigators, the SEER data, and the ECOG/Intergroup study have shown that
patients with small tumors (< 0.5 cm) have a recurrence rate of less than 2%, compared to 20 …

Metastatic behavior of breast cancer subtypes

H Kennecke, R Yerushalmi, R Woods… - Journal of clinical …, 2010 - ascopubs.org
Purpose Prognostic and predictive factors are well established in early-stage breast cancer,
but less is known about which metastatic sites will be affected. Methods Patients with early …

Patterns of recurrence and outcome according to breast cancer subtypes in lymph node–negative disease: results from International Breast Cancer Study Group Trials …

O Metzger-Filho, Z Sun, G Viale, KN Price… - Journal of clinical …, 2013 - ascopubs.org
Purpose To retrospectively evaluate the pattern of recurrence and outcome of node-negative
breast cancer (BC) according to major subtypes. Patients and Methods In all, 1,951 patients …

Breast cancer subtypes predispose the site of distant metastases

A Soni, Z Ren, O Hameed, D Chanda… - American journal of …, 2015 - academic.oup.com
Objectives: The distant organs to which breast cancer preferentially metastasizes are of
significant clinical importance. Methods: We explored the relationship between the …

Metabolic flare: indicator of hormone responsiveness in advanced breast cancer

JE Mortimer, F Dehdashti, BA Siegel… - Journal of Clinical …, 2001 - ascopubs.org
PURPOSE: The purpose of this study was to investigate whether positron emission
tomography (PET) with the glucose analog [18F] fluorodeoxyglucose (FDG) and the …

Estrogen receptors and distinct patterns of breast cancer relapse

KR Hess, L Pusztai, AU Buzdar… - Breast cancer research …, 2003 - Springer
Background. We conducted an analysis of prospectively collected data to compare the
clinical behavior of ER-negative versus ER-positive tumors with respect to rates and sites of …

Expression of c‐met is a strong independent prognostic factor in breast carcinoma

RAD Ghoussoub, DA Dillon, T D'Aquila… - … Journal of the …, 1998 - Wiley Online Library
BACKGROUND The c‐met protooncogene encodes the met protein, the receptor for scatter
factor/hepatocyte growth factor, a growth factor that modulates the motility and stable …

A combination of GATA3 and SOX10 is useful for the diagnosis of metastatic triple-negative breast cancer

GH Tozbikian, DL Zynger - Human pathology, 2019 - Elsevier
In metastatic breast cancer (MBC), it can be difficult to establish the origin if the primary
tumor is triple negative or if there is a loss of biomarker expression. SOX10 expression has …

Met expression is associated with poor outcome in patients with axillary lymph node negative breast carcinoma

RL Camp, EB Rimm, DL Rimm - … International Journal of the …, 1999 - Wiley Online Library
BACKGROUND Activation of Met, the receptor for scatter factor/hepatocyte growth factor, is
associated with mitogenesis, motogenesis, and decreased cell adhesion. Elevated …